Hydrogen Carrier Gas for GC/MS/MS Analysis of Steroids in Urine in Under 10 Minutes
Applications | 2025 | Agilent TechnologiesInstrumentation
Reliable detection and quantification of endogenous anabolic–androgenic steroids in urine are critical for anti-doping laboratories to comply with World Anti-Doping Agency (WADA) requirements and uphold fair competition. The replacement of helium with hydrogen as a carrier gas addresses global helium shortages and escalating costs, offering a sustainable, cost-effective, and high-throughput analytical solution.
This work aimed to develop and validate a rapid GC/MS/MS method using hydrogen carrier gas to quantify 14 endogenous anabolic steroids in urine within 10 minutes. The method targets a 40% reduction in run time compared to traditional helium-based protocols while meeting WADA limits of identification (LOIs) and demonstrating comparable analytical performance.
The hydrogen method achieved baseline separation of all steroid isomers in under 10 minutes, reducing analysis time by 40%. Calibration curves exhibited R² values above 0.997 across the required concentration ranges, meeting WADA MRPL and LOI criteria. No spectral changes were observed when using the standard Inert Plus EI source with hydrogen, and WADA external quality assessment (EQAS) samples produced z-scores below 1 for six analytes, confirming high accuracy and robustness.
Broader adoption of hydrogen carrier gas in GC/MS workflows can extend to unknown-compound screening and analyses of hydrogen-reactive analytes using HydroInert sources. Coupling with automated high-throughput sample preparation and embracing sustainable laboratory practices will further enhance efficiency and environmental responsibility.
The validated hydrogen-based GC/MS/MS method delivers rapid, accurate, and robust quantification of endogenous anabolic steroids in urine, ensuring compliance with anti-doping standards while reducing analysis time and environmental impact.
1. World Anti-Doping Agency. TD2022MRPL: Minimum Required Performance Levels for Detection and Identification of Non-Threshold Substances. WADA, 2022.
2. Van Gansbeke W.; Albertsdóttir Á.D.; Polet M.; Van Eenoo P.; Nieto S. Introducing Semi-Automated GC/Q-TOF Screening with the AssayMAP Bravo Sample Prep Platform for Antidoping Control. Agilent Technologies Application Note 5994-6702EN, 2023.
3. Van Eenoo P.; Van Gansbeke W.; De Brabanter N.; Deventer K.; Delbeke F.T. A Fast, Comprehensive Screening Method for Doping Agents in Urine by Gas Chromatography-Triple Quadrupole Mass Spectrometry. J. Chromatogr. A 2011, 1218, 3306–3316.
4. Polet M.; Van Gansbeke W.; Van Eenoo P. Development and Validation of an Open Screening Method for Doping Substances in Urine by Gas Chromatography Quadrupole Time-of-Flight Mass Spectrometry. Anal. Chim. Acta 2018, 1042, 52–59.
5. Agilent Technologies. Agilent EI GC/MS Instrument Helium to Hydrogen Carrier Gas Conversion User Guide; 5994-2312EN, 2022.
6. Van Gansbeke W.; et al. Improved Sensitivity by Use of Gas Chromatography-Positive Chemical Ionization Triple Quadrupole Mass Spectrometry for the Analysis of Drug Related Substances. J. Chromatogr. B 2015, 1001, 221–240.
7. Agilent Technologies. Agilent Inert Plus GC/MS System with HydroInert Source Technical Overview; 5994-4889EN, 2022.
GC/MSD, GC/MS/MS, GC/QQQ
IndustriesForensics
ManufacturerAgilent Technologies
Summary
Significance of the Topic
Reliable detection and quantification of endogenous anabolic–androgenic steroids in urine are critical for anti-doping laboratories to comply with World Anti-Doping Agency (WADA) requirements and uphold fair competition. The replacement of helium with hydrogen as a carrier gas addresses global helium shortages and escalating costs, offering a sustainable, cost-effective, and high-throughput analytical solution.
Objectives and Study Overview
This work aimed to develop and validate a rapid GC/MS/MS method using hydrogen carrier gas to quantify 14 endogenous anabolic steroids in urine within 10 minutes. The method targets a 40% reduction in run time compared to traditional helium-based protocols while meeting WADA limits of identification (LOIs) and demonstrating comparable analytical performance.
Methodology and Instrumentation
- Sample Preparation: Automated solid-phase extraction (SPE) on Bond Elut NEXUS cartridges, enzymatic hydrolysis, liquid–liquid extraction with methyl tert-butyl ether, and derivatization using MSTFA/NH4I/ethanethiol.
- Instrumentation: Agilent 7000C triple quadrupole GC/MS with Inert Plus EI source; hydrogen carrier gas at 1 mL/min; splitless injection of 1.5 µL; 12 m × 0.20 mm, 0.11 µm column; temperature program from 120 °C to 300 °C in 9.64 min.
- Calibration: Six-level, deuterated internal standard calibration curves with 1/x-weighted quadratic fits for each steroid.
- Data Processing: Agilent MassHunter acquisition and quantitative analysis software.
Main Results and Discussion
The hydrogen method achieved baseline separation of all steroid isomers in under 10 minutes, reducing analysis time by 40%. Calibration curves exhibited R² values above 0.997 across the required concentration ranges, meeting WADA MRPL and LOI criteria. No spectral changes were observed when using the standard Inert Plus EI source with hydrogen, and WADA external quality assessment (EQAS) samples produced z-scores below 1 for six analytes, confirming high accuracy and robustness.
Benefits and Practical Applications
- Throughput Improvement: Sub-10-minute runs increase daily sample capacity.
- Regulatory Compliance: Maintains sensitivity and selectivity required by WADA for endogenous steroids.
- Cost and Sustainability: Hydrogen is more abundant, less expensive, and can be produced via green electrolysis.
- Instrument Uptime: Hydrogen carrier gas keeps the EI source cleaner, reducing maintenance.
Future Trends and Opportunities
Broader adoption of hydrogen carrier gas in GC/MS workflows can extend to unknown-compound screening and analyses of hydrogen-reactive analytes using HydroInert sources. Coupling with automated high-throughput sample preparation and embracing sustainable laboratory practices will further enhance efficiency and environmental responsibility.
Conclusion
The validated hydrogen-based GC/MS/MS method delivers rapid, accurate, and robust quantification of endogenous anabolic steroids in urine, ensuring compliance with anti-doping standards while reducing analysis time and environmental impact.
References
1. World Anti-Doping Agency. TD2022MRPL: Minimum Required Performance Levels for Detection and Identification of Non-Threshold Substances. WADA, 2022.
2. Van Gansbeke W.; Albertsdóttir Á.D.; Polet M.; Van Eenoo P.; Nieto S. Introducing Semi-Automated GC/Q-TOF Screening with the AssayMAP Bravo Sample Prep Platform for Antidoping Control. Agilent Technologies Application Note 5994-6702EN, 2023.
3. Van Eenoo P.; Van Gansbeke W.; De Brabanter N.; Deventer K.; Delbeke F.T. A Fast, Comprehensive Screening Method for Doping Agents in Urine by Gas Chromatography-Triple Quadrupole Mass Spectrometry. J. Chromatogr. A 2011, 1218, 3306–3316.
4. Polet M.; Van Gansbeke W.; Van Eenoo P. Development and Validation of an Open Screening Method for Doping Substances in Urine by Gas Chromatography Quadrupole Time-of-Flight Mass Spectrometry. Anal. Chim. Acta 2018, 1042, 52–59.
5. Agilent Technologies. Agilent EI GC/MS Instrument Helium to Hydrogen Carrier Gas Conversion User Guide; 5994-2312EN, 2022.
6. Van Gansbeke W.; et al. Improved Sensitivity by Use of Gas Chromatography-Positive Chemical Ionization Triple Quadrupole Mass Spectrometry for the Analysis of Drug Related Substances. J. Chromatogr. B 2015, 1001, 221–240.
7. Agilent Technologies. Agilent Inert Plus GC/MS System with HydroInert Source Technical Overview; 5994-4889EN, 2022.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Staying ahead of regulations for the analysis of steroids in urine with GC-MS/MS
2023|Thermo Fisher Scientific|Applications
Technical note | 001896 Anti-doping Staying ahead of regulations for the analysis of steroids in urine with GC-MS/MS Authors Goal Łukasz Rajski , Adam Ladak and The goal of this technical note is to demonstrate the utility of the Thermo…
Key words
etiocholanolone, etiocholanoloneandrosterone, androsteronemethylstenbolone, methylstenbolonecalusterone, calusteronemrl, mrlfurazabol, furazaboltestosterone, testosteroneclenbuterol, clenbuterolzilpaterol, zilpaterolmin, minepitestosterone, epitestosteronemrpl, mrplprohibited, prohibiteddoping, dopinghold
Fast and Comprehensive Doping Agent Screening in Urine by Triple Quadrupole GC/MS
2011|Agilent Technologies|Applications
Fast and Comprehensive Doping Agent Screening in Urine by Triple Quadrupole GC/MS Application Note Forensic Toxicology Authors Abstract Peter van Eenoo, Wim Van Gansbeke Nik De Brabanter, Koen Deventer A rapid analytical method was developed on the Agilent 7000 Series…
Key words
excr, excrmrpl, mrplandrosterone, androsteronetransitions, transitionsprohibited, prohibitedparent, parentsubstances, substancesetiocholanolone, etiocholanolonedoping, dopingtms, tmswada, wadasubstance, substancemethod, methodcollision, collisionendogenous
Extend the time window for the detection of low level anabolic‑androgenic steroids and their metabolites
2018|Agilent Technologies|Applications
Application Note Doping Control Extend the time window for the detection of low level anabolic‑androgenic steroids and their metabolites Steroid profiling, screening, and confirmatory analysis using the Agilent 7010 GC/MS mass spectrometer Author Joachim Grosse Institute of Doping Analysis and…
Key words
doping, dopingtestosterone, testosteroneetiocholanolone, etiocholanoloneandrosterone, androsteronesteroid, steroidwada, wadaabundance, abundancenonconjugated, nonconjugatedepitestosterone, epitestosteronemarkers, markersendogenous, endogenousbackflush, backflushexogenous, exogenousanabolic, anabolicmoiety
Introducing Semi-Automated GC/Q-TOF Screening with the AssayMAP Bravo Sample Prep Platform for Antidoping Control
2023|Agilent Technologies|Applications
Application Note Forensics and Toxicology Introducing Semi-Automated GC/Q-TOF Screening with the AssayMAP Bravo Sample Prep Platform for Antidoping Control Authors Wim Van Gansbeke, Aðalheiður Dóra Albertsdóttir, Michaël Polet, and Peter Van Eenoo DoCoLab, Ghent University, Ghent, Belgium Sofia Nieto Agilent…
Key words
assaymap, assaymapbravo, bravosulfated, sulfatedmetabolites, metabolitesdoping, dopingtof, tofsteroids, steroidsnonhydrolyzed, nonhydrolyzedmetenolone, metenolonewada, wadamesterolone, mesterolonehydrolyzed, hydrolyzedlle, lleaas, aasautomated